PSG — PharmaSGP Holding SE Share News
0.000.00%
Last trade - 00:00- €368.40m
- €400.59m
- €118.84m
Brief: PharmaSGP Holding Outlook FY Adjusted EBITDA EUR 37-39 Million
Brief: PharmaSGP Holding Q1 Adjusted EBITDA EUR 9.2 Million
Brief: PharmaSGP Holding Outlook FY Revenue EUR 122-128 Million
Brief: PharmaSGP Holding 9M Adjusted EBITDA EUR 27 Million
Brief: PharmaSGP Holding H1 Adjusted EBITDA EUR 16.9 Million
Europe Research Roundup: AB Dynamics, Etteplan, Wise
Brief: PharmaSGP Holding Q1 Adjusted EBITDA EUR 8.9 Million
Brief: PharmaSGP Holding Outlook FY Revenue EUR 107-112 Million
Brief: PharmaSGP Holding 9M EBITDA EUR 24.8 Million
Europe Research Roundup: Bpost SA, Castellum AB, Vesuvius
Europe Research Roundup: DSV, Spire Healthcare Group, Standard Chartered
Brief: Pharmasgp Holding SE Expects Consolidated Revenues In Range Of Eur 91 Million To Eur 96 Million For FY 2023
Brief: PharmaSGP Q1 EBITDA Up 135% To EUR 5.0 Mln
Brief: PharmaSGP Management Board To Propose Dividend Amounting To 50% Of Net Income
Brief: Pharmasgp Holding FY Adjusted EBITDA EUR 19.4 Mln
Brief: PharmaSGP FY 2021 Revenues At Around EUR 65 Mln
Brief: PharmaSGP 9-Month Adj. EBITDA At EUR 13.2 Mln
Brief: PharmaSGP Holding H1 Adj. EBITDA Down At EUR 6.5 Mln
Brief: PharmaSGP Takes Up Further Shareholder Loan From Futrue